99 related articles for article (PubMed ID: 30149365)
21. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
22. T homozygote and allele of epidermal growth factor receptor 2073 gene polymorphism are associated with higher susceptibility to endometriosis and leiomyomas.
Hsieh YY; Chang CC; Tsai FJ; Lin CC; Tsai CH
Fertil Steril; 2005 Mar; 83(3):796-9. PubMed ID: 15749523
[TBL] [Abstract][Full Text] [Related]
23. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
[TBL] [Abstract][Full Text] [Related]
24. Replication of GWAS loci revealed the moderate effect of TNRC6B locus on susceptibility of Saudi women to develop uterine leiomyomas.
Bondagji NS; Morad FA; Al-Nefaei AA; Khan IA; Elango R; Abdullah LS; M Al-Mansouri N; Sabir J; Banaganapalli B; Edris S; Shaik NA
J Obstet Gynaecol Res; 2017 Feb; 43(2):330-338. PubMed ID: 27987337
[TBL] [Abstract][Full Text] [Related]
25. Influence of vitamin D and transforming growth factor β3 serum concentrations, obesity, and family history on the risk for uterine fibroids.
Ciebiera M; Włodarczyk M; Słabuszewska-Jóźwiak A; Nowicka G; Jakiel G
Fertil Steril; 2016 Dec; 106(7):1787-1792. PubMed ID: 27743697
[TBL] [Abstract][Full Text] [Related]
26. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma.
Di Tommaso S; Tinelli A; Malvasi A; Massari S
Mol Hum Reprod; 2014 Oct; 20(10):1009-15. PubMed ID: 25015674
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical localization of selected pro-inflammatory factors in uterine myomas and myometrium in women of various ages.
Plewka A; Madej P; Plewka D; Kowalczyk A; Miskiewicz A; Wittek P; Leks T; Bilski R
Folia Histochem Cytobiol; 2013; 51(1):73-83. PubMed ID: 23690221
[TBL] [Abstract][Full Text] [Related]
28. [Detection of epidermal growth factor receptor gene mutations in non-small cell lung cancers by real-time polymerase chain reaction using scorpion amplification refractory mutation system].
Zhang J; Liang ZY; Zeng X; Wu SF; Gao J; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):294-9. PubMed ID: 18956645
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of p53 promoter and susceptibility to uterine leiomyoma.
Ziaei E; Chaleshtori MH; Ziaei A; Dehkordi GB; Pooryamofrad A; Kashani S; Batenipoor M; Miraj S
Clin Exp Obstet Gynecol; 2016; 43(5):713-717. PubMed ID: 30074324
[TBL] [Abstract][Full Text] [Related]
30. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.
Wei T; Geiser AG; Qian HR; Su C; Helvering LM; Kulkarini NH; Shou J; N'Cho M; Bryant HU; Onyia JE
BMC Womens Health; 2007 Apr; 7():5. PubMed ID: 17407572
[TBL] [Abstract][Full Text] [Related]
31. Uterine leiomyoma is associated with a polymorphism in the interleukin 1-beta gene.
Pietrowski D; Thewes R; Sator M; Denschlag D; Keck C; Tempfer C
Am J Reprod Immunol; 2009 Aug; 62(2):112-7. PubMed ID: 19614627
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factors II exon 9 and E-cadherin-Pml I but not myeloperoxidase promoter-463, urokinase-ApaL I nor xeroderma pigmentosum polymorphisms are associated with higher susceptibility to leiomyoma.
Hsieh YY; Chang CC; Wang YK; Hsu KH; Chen CP; Hsu CM; Tsai FJ
Anticancer Res; 2010 Jun; 30(6):2203-8. PubMed ID: 20651370
[TBL] [Abstract][Full Text] [Related]
33.
Akbari M; Abedin Do A; Yassaee F; Mirfakhraie R
Rep Biochem Mol Biol; 2019 Apr; 8(1):21-24. PubMed ID: 31334283
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor-alpha gene (T/C) Pvu II polymorphism in endometriosis and uterine fibroids.
Govindan S; Shaik NA; Vedicherla B; Kodati V; Rao KP; Hasan Q
Dis Markers; 2009; 26(4):149-54. PubMed ID: 19729795
[TBL] [Abstract][Full Text] [Related]
35. Selective genetic analysis of myoma pseudocapsule and potential biological impact on uterine fibroid medical therapy.
Di Tommaso S; Massari S; Malvasi A; Vergara D; Maffia M; Greco M; Tinelli A
Expert Opin Ther Targets; 2015 Jan; 19(1):7-12. PubMed ID: 25363374
[TBL] [Abstract][Full Text] [Related]
36. [Mutation status of epidermal growth factor receptor and KRAS gene in non-small cell lung cancers at Xuanwei regions of Yunnan Province].
Yang CS; Pan XY; Feng Q; Wang YY; Xu WM; Jiang T; Wang L; Yang JL; Wang L
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):226-30. PubMed ID: 27033384
[TBL] [Abstract][Full Text] [Related]
37. [Bioinformatic investigation of the involvement of candidate genes of cytokines in the formation of large myomatous nodes in women with uterine cancer in older age groups].
Altuhova OB; Sirotina SS; Ponomarenko IV; Prashchayeu KI; Anichkov NM; Churnosov MI; Shaginian GG
Adv Gerontol; 2016; 29(5):717-721. PubMed ID: 28556639
[TBL] [Abstract][Full Text] [Related]
38. Radiofrequency Thermal Ablation for Uterine Myomas: Long-term Clinical Outcomes and Reinterventions.
Iversen H; Dueholm M
J Minim Invasive Gynecol; 2017; 24(6):1020-1028. PubMed ID: 28662989
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.
Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG
Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
Karmon AE; Cardozo ER; Rueda BR; Styer AK
Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]